HIV and the Female Genital Tract -- What Does It Mean for HIV Prevention?
- Public Health Agency of Canada. Summary: Estimates of HIV Prevalence and Incidence in Canada, 2014. Surveillance and Epidemiology Division, Professional Guidelines and Public Health Practice Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, 2015. Available from: www.catie.ca/en/resources/summary-estimates-hiv-incidence-prevalence-and-proportion-undiagnosed-canada-2014
- Kaul R, Pettengell C, Sheth PM, et al. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission. Journal of Reproductive Immunology. 2008;77:32-40.
- Boily M-C, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infectious Diseases. 2009 Feb;9(2):118-29.
- Petrova MI, Van den Broek M, Balzarini J, et al. Vaginal microbiota and its role in HIV transmission and infection. FEMS Microbiology Reviews. 2013 Sept 1;37(5):762-92.
- Wira CR, Rodriguez-Garcia M, Patel MV. The role of sex hormones in immune protection of the female reproductive tract. Nature Reviews Immunology. 2015 Mar 6;15(4):217-30.
- Hladik F and McElrath MJ. Setting the stage: Host invasion by HIV. Nature Reviews Immunology. 2008 Jun 1;8(6):447-57.
- Lai SK, Hida K, Shukair S, et al. Human Immunodeficiency Virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. Journal of Virology. 2009 Nov 1;83(21):11196-200.
- Griesbeck M and Altfeld M. "Sex Differences in the Manifestations of HIV-1 Infection." In Sex and Gender Differences in Infection and Treatments for Infectious Diseases, 103-81. Springer, 2015. Available from: http://link.springer.com/chapter/10.1007/978-3-319-16438-0_5.
- Adimora AA, Ramirez C, Auerbach JD, et al. Preventing HIV infection in women. Journal of Acquired Immune Deficiency Syndromes. 2013 Jul 1;63 Suppl 2:S168-73.
- Masson L, Passmore JS, Liebenberg LJ, et al. Genital inflammation and the risk of HIV acquisition in women. Clinical Infectious Diseases. 2015 Jul 15;61(2):260-69.
- Brown JM, Wald A, Hubbard A, et al. Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe. AIDS. 2007;21:1515-23.
- Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006;20:73-83.
- Shannon B, Yi TJ, Thomas-Pavanel J, et al. Impact of asymptomatic herpes simplex virus type 2 infection on mucosal homing and immune cell subsets in the blood and female genital tract. The Journal of Immunology. 2014 Jun 1;192(11):5074-82.
- Thurman AR, Doncel G. Innate immunity and inflammatory response to trichomonas vaginalis and bacterial vaginosis: Relationship to HIV acquisition. American Journal of Reproductive Immunology. 2011;65:89-98.
- Thurman AR, Kimble T, Herold B, et al. Bacterial vaginosis and subclinical markers of genital tract inflammation and mucosal immunity. AIDS Research and Human Retroviruses. 2015 July 23;31(11):1139-52.
- Morrison CS, Chen P, Kwok C, et al. Hormonal contraception and the risk of HIV acquisition: An individual participant data meta-analysis. PLoS Medicine. 2015 Jan;12(1):e1001778. Available from: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001778.
- Polis CB, Phillips SJ, Curtis KM, et al. Hormonal contraceptive methods and risk of HIV acquisition in women: A systematic review of epidemiological evidence. Contraception. 2014 Oct 1;90(4):360-90.
- Weeks M. Female condom use and adoption among men and women in a general low-income urban U.S. population. AIDS and Behavior. 2015 Sept 1;19(9):1642-54.
- Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine. 2011 Aug 11;365(6):493-505.
- Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine. 2012 Aug 2;367(5):399-410.
- Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. New England Journal of Medicine. 2012 Aug 2;367(5):423-34.
- Marrazzo JM, Ramjee G, Richardson BA, et al. Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women. New England Journal of Medicine. 2015 Feb 5;372(6):509-18.
- Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. New England Journal of Medicine. 2012 Aug 2;367(5):411-22.
- Cottrell ML, Yang KH, Prince H, et al. A translational pharmacology approach to predicting HIV pre-exposure prophylaxis outcomes in men and women using tenofovir disproxil fumarate + emtricitabine. Journal of Infection Diseases. 2016; in press.
- Loutfy MR, Macdonald S, Myhr T, et al. Prospective cohort study of HIV post-exposure prophylaxis for sexual assault survivors. Antiviral Therapy. 2008 Jan;13:87-95.
- Sultan B, Benn P, Waters L. Current perspectives in HIV post-exposure prophylaxis. HIV/AIDS -- Research and Palliative Care. 2014;6:147-58.
- U.S. Centers for Disease Control and Prevention. Provider Information Sheet -- PrEP During Conception, Pregnancy, and Breastfeeding. Available from: www.cdc.gov/hiv/pdf/prep_gl_clinician_factsheet_pregnancy_english.pdf.
- Loutfy MR, Margolese S, Money DM, et al. Canadian HIV Pregnancy Planning Guidelines. SOGC Clinical Practice Guideline. Jun 2012; No.278. Available from: http://sogc.org/wp-content/uploads/2012/09/gui278CPG1206E1.pdf.
No comments have been made.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy